DELTA-FLY PHARMA INC has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in China, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are G L PHARMA GMBH, NIPPON BIOLOG INC and BIONICHE UROLOGY IP INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Republic of Korea | 3 | |
#4 | Taiwan | 3 | |
#5 | Hong Kong | 2 | |
#6 | Hungary | 2 | |
#7 | United States | 2 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Measurement | |
#7 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Wada Hiromi | 9 |
#2 | Fukushima Masakazu | 8 |
#3 | Ishida Tatsuhiro | 8 |
#4 | Eshima Kiyoshi | 6 |
#5 | Huang Cheng-Long | 2 |
#6 | Oyama Ryo | 2 |
#7 | Huang Cheng Long | 2 |
#8 | Yamada Shozo | 2 |
#9 | Ashley Gary | 1 |
#10 | Cheng He Jin | 1 |
Publication | Filing date | Title |
---|---|---|
US2017319713A1 | Method for producing lipoplex for topical administration and antitumor agent using such lipoplex | |
HUE029171T2 | Rnai molecule for thymidylate synthase and use thereof |